Patents by Inventor Darren Arthur Vee-Yip Yuen

Darren Arthur Vee-Yip Yuen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and uses of slit for treating fibrosis
    Patent number: 9974829
    Abstract: The present disclosure provides methods and uses of Slit protein and nucleic acid for inhibiting fibrosis and fibrotic-related disorders, for example, of the kidney, lung, heart, liver, or a wound. The Slit protein can be, for example, Slit2 or Slit2-N, or a Slit variant that can bind the Robo receptor and induce signalling. Also provided are pharmaceutical compositions comprising the Slit protein or nucleic acid and an additional anti-fibrotic agent.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 22, 2018
    Assignee: The Hospital for Sick Children
    Inventors: Lisa Annette Robinson, Darren Arthur Vee-Yip Yuen
  • METHODS AND USES OF SLIT FOR TREATING FIBROSIS
    Publication number: 20170281726
    Abstract: The present disclosure provides methods and uses of Slit protein and nucleic acid for inhibiting fibrosis and fibrotic-related disorders, for example, of the kidney, lung, heart, liver, or a wound. The Slit protein can be, for example, Slit2 or Slit2-N, or a Slit variant that can bind the Robo receptor and induce signalling. Also provided are pharmaceutical compositions comprising the Slit protein or nucleic acid and an additional anti-fibrotic agent.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 5, 2017
    Inventors: Lisa Annette Robinson, Darren Arthur Vee-Yip Yuen
  • Methods and uses of slit for treating fibrosis
    Patent number: 9700593
    Abstract: The present disclosure provides methods and uses of Slit protein and nucleic acid for inhibiting fibrosis and fibrotic-related disorders, for example, of the kidney, lung, heart, liver, or a wound. The Slit protein can be, for example, Slit2 or Slit2-N, or a Slit variant that can bind the Robo receptor and induce signalling. Also provided are pharmaceutical compositions comprising the Slit protein or nucleic acid and an additional anti-fibrotic agent.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: July 11, 2017
    Assignee: The Hospital for Sick Children
    Inventors: Lisa Annette Robinson, Darren Arthur Vee-Yip Yuen
  • METHODS AND USES OF SLIT FOR TREATING FIBROSIS
    Publication number: 20160120940
    Abstract: The present disclosure provides methods and uses of Slit protein and nucleic acid for inhibiting fibrosis and fibrotic-related disorders, for example, of the kidney, lung, heart, liver, or a wound. The Slit protein can be, for example, Slit2 or Slit2-N, or a Slit variant that can bind the Robo receptor and induce signalling. Also provided are pharmaceutical compositions comprising the Slit protein or nucleic acid and an additional anti-fibrotic agent.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 5, 2016
    Inventors: Lisa Annette Robinson, Darren Arthur Vee-Yip Yuen